14 February 2025 |

Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform

MILAN, Feb. 13, 2025 /PRNewswire/ — Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 million Series B funding round. The financing was led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation from existing investors Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, and

25 September 2019 |

Newronika raises €8.4M Series A Round

MILAN, 25th SEPTEMBER 2019 – Newronika, a spin-off of world-class neurological research center Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together withexisting investors Innogest and Indaco Venture Partners SGR (“Indaco SGR”) on behalf of Indaco Ventures I and Atlante Ventures funds.

14 June 2016 |

Newronika (deep brain stimulation) receives first financing round of €1.7 M

Newronika, an innovative medtech startup specializing in neuromodulation therapies, has received a first financing round totalling €1.7 M from a group of investors led by Innogest SGR Spa, together with Atlante Ventures, VC arm of the Intesa Sanpaolo Group, and F3F SpA, investment company owned by Laura Iris Ferro